![]() |
||||
|
||||
|
|
||||
Re: ErythropoietinFrom: Dr James Lie (splaz@cyllene.uwa.edu.au)Sun Jan 25 18:11:40 2004
1. EPO is administered twice or thrice weekly, intravenously or (more usually) subcutaneously. The principal side effect is impaired control of hypertension. Body iron stores are critical in maintaining the erythropoietic response. Parenteral iron saccharate can reduce the maintenance dose of EPO. 2. however there is no evidence that once weekly is any worse than 2/3 times a week, see Cochrane's review: http://www.update-software.com/abstracts/AB003895.htm 3. and Tarng et Huang http://ndt.oupjournals.org/cgi/content/abstract/13/11/2867 found that it is iv vitamin C rather than iron that increases iron utilisation in the erythron. 4. re length of time - see case presentation: http://www.blackwell-synergy.com/links/doi/10.1046/j.1460-9592.2003.01012.x/ abs/ Hb33 - EPO given for 4 days before surgery and 10 days postop. 5. an unsourced quote: "Patients who receive six shots of erythropoietin in the weeks before surgery have the equivalent of two extra pints of blood in their body when they enter the operating room"
-- James Lie Australia
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Fri May 2 04:37:39 2008 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.